Deaths in Indian clinical trials result in few payments

03/13/2013 | Business Standard (India)

While 2,868 deaths were reported during clinical trials from 2005 to 2012, the Indian government found only 89 to be directly attributable to the trials. To date, compensation has been paid in only 45 cases. The government has established four committees to monitor the fast-growing growing clinical-trial industry in India, mandating strict requirements for reporting adverse events, including deaths, according to the Ministry of Health and Family Welfare.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC